Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:1074-1079
Published online before print March 8, 2004, doi: 10.1161/01.HYP.0000123074.89717.3d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/5/1074    most recent
01.HYP.0000123074.89717.3dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, M. J.
Right arrow Articles by Sigmund, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, M. J.
Right arrow Articles by Sigmund, C. D.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2004;43:1074.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Angiotensin II–Induced Vascular Dysfunction Is Mediated by the AT1A Receptor in Mice

Michael J. Ryan; Sean P. Didion; Satya Mathur; Frank M. Faraci; Curt D. Sigmund

From the Departments of Internal Medicine (M.J.R., S.P.D., S.M. F.M.F., C.D.S.), Pharmacology (F.M.F.), and Physiology and Biophysics (C.D.S.), Cardiovascular Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.

Correspondence to Michael J. Ryan, PhD, Department of Internal Medicine, University of Iowa, 3181 MEBRF, Iowa City, IA 52242. E-mail ryanm{at}physiology.uiowa.edu

Many of the actions of angiotensin II (Ang II) are mediated by angiotensin type 1 receptors (AT1), of which there are 2 pharmacologically indistinguishable subtypes (AT1A and AT1B). The purpose of this study was to evaluate the effect of an AT1A homozygous deletion (AT1A–/–) on vascular reactivity. AT1A–/– mice and control littermates (AT1A+/+) were infused with vehicle (saline) or Ang II (1000 ng · kg–1 · min–1) for 7 days by osmotic pumps. Systolic pressure was increased in AT1A+/+ mice ({Delta}45±8 mm Hg, P<0.0001) but unchanged in AT1A–/– mice ({Delta}5±3 mm Hg, P>0.13) on day 7. The carotid artery response to the vasodilators acetylcholine (ACh), nitroprusside, and papaverine and to the vasoconstrictors phenylephrine, U46619, 5-hydroxytryptamine (5-HT), and KCl were not different between vehicle-infused AT1A+/+ and AT1A–/– animals. Carotid relaxation to ACh was impaired and contraction to 5-HT was increased in Ang II–infused AT1A+/+ mice. Ang II did not affect carotid responses in AT1A–/– mice. Superoxide, measured by lucigenin (5 µmol/L), and hydroethidine staining were not different between AT1A+/+ and AT1A–/– mice after vehicle or Ang II infusion, suggesting that it was not contributing to the altered ACh and 5-HT responses. The Rho-kinase inhibitor Y-27632 (1 µmol/L) attenuated the 5-HT response in both vehicle- and Ang II–infused AT1A+/+ mice. Moreover, concentration-dependent relaxation to Y-27632 and RhoA protein expression were not different in vehicle- or Ang II–infused AT1A+/+. These data demonstrate that the AT1A receptor is required for Ang II–induced changes in carotid artery function.


Key Words: endothelium • receptors, angiotensin II • carotid arteries • acetylcholine




This article has been cited by other articles:


Home page
HypertensionHome page
S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, Y. Chu, and F. M. Faraci
Endogenous Interleukin-10 Inhibits Angiotensin II-Induced Vascular Dysfunction
Hypertension, September 1, 2009; 54(3): 619 - 624.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion
IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2576 - 2581.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. C. Hercule, J. Tank, R. Plehm, M. Wellner, A. C. da Costa Goncalves, M. Gollasch, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross
Cardiovascular Control: Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice
Exp Physiol, November 1, 2007; 92(6): 1014 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb
Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Didion, C. M. Lynch, and F. M. Faraci
Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1579 - H1583.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola
Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II
Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 303 - 309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Ryan and G. R. McLemore Jr.
Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R736 - R742.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells
Hypertension, October 1, 2006; 48(4): 534 - 540.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Harrison-Bernard, C. J. Monjure, and B. J. Bivona
Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1177 - F1186.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola
Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2-Derived Radicals
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 826 - 832.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci
Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction
Hypertension, November 1, 2005; 46(5): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Wesseling, D. A. Ishola Jr., J. A. Joles, H. A. Bluyssen, H. A. Koomans, and B. Braam
Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1191 - F1200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. G. Barnes, E. Reiter, J. D. Violin, X.-R. Ren, G. Milligan, and R. J. Lefkowitz
{beta}-Arrestin 1 and G{alpha}q/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
J. Biol. Chem., March 4, 2005; 280(9): 8041 - 8050.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Vazquez, M. F. C. de Adjounian, C. Sumners, A. Gonzalez, C. Diez-Freire, and M. K. Raizada
Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference
Hypertension, January 1, 2005; 45(1): 115 - 119.
[Abstract] [Full Text] [PDF]